Press Releases

June 5 2013

House Bill 365, signed by Governor Rick Scott, contains four of BIO’s five principles on...

April 3 2013

The Biotechnology Industry Organization (BIO) and ...

March 21 2013

In statehouses around the country, lawmakers are beginning to address the complexities of...

January 23 2013

Ken Lisaius has been named Vice President of Communications at BIO.

July 27 2012

The measure forces certain companies to pay for disposal.

March 2 2012

The Biotechnology Industry Organization (BIO) announced today that it has integrated its...

January 17 2012

Bittenbender will spearhead BIO’s engagement in and support of state-level legislative...

November 16 2011

"The most important return on investment from this initiative would be the creation of...

October 26 2011

 BIO Commends Governor Nixon and Missouri Legislature for Commitment to Industry

September 28 2011

The Mississippi Biotechnology Association has joined the Council of State Bioscience...

June 9 2011

Governor Quinn will be presented with the award on June 29th, 2011...

June 8 2011

BIO announces that Governor Pat Quinn has been selected as the 2011 BIO Governor of the Year...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Congressman...

March 3 2011

The Virginia Refundable Research and Development Tax Credit, recently passed by the Virginia...

February 9 2011

BIO and several of its member companies will offer input on progress and potential adjustments...

Letters, Testimony & Comments

May 8 2013
BIO  urges Florida Governor Scott to sign House Bill 365 – a bill related to the substitution of biologic and biosimilar medicines – which recently passed out of the Legislature.
February 1 2013
BIO supports passage of Florida House Bill 365, which provides requirements for pharmacist to dispense substitute biological products that are determined to be interchangeable for prescribed biological product.
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
January 24 2013
The policies outlined in Senate Bill 2190 align with all five of BIO’s Principles on Biologic Product Substitution and we therefore support its passage.
January 24 2013
BIO opposes the proposal to subject certain cancer therapies to prior authorization measures under Senate Bill 2066.

Press Releases

June 7 2013
Oregon Governor John Kitzhaber signed legislation on Thursday, June 6 designed to address the regulatory issues related to the interchangeability of biological medicines.
June 5 2013
House Bill 365, signed by Governor Rick Scott, contains four of BIO’s five principles on biologic product substitution
April 3 2013
The Biotechnology Industry Organization (BIO) and BioFlorida commend the Florida Senate Committee on Health Policy for passage of Senate Bill 732 out of committee.
March 21 2013
In statehouses around the country, lawmakers are beginning to address the complexities of cutting-edge biotech drugs and the regulatory issues related to the interchangeability of biosimilar medicines.
January 23 2013
Ken Lisaius has been named Vice President of Communications at BIO.